Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs » Insulin

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Exenatide As Effective As Insulin Posted: Thursday, October 12, 2006

Patients on exenatide lost weight, while insulin patients gained weight.

Role of Blood Glucose Self-Monitoring in Medicare Patients with Type 2 Diabetes Posted: Thursday, October 12, 2006

The Centers for Medicare and Medicaid Services is questioning whether or not Patients with Type 2 Diabetes benefit from self-monitoring of their blood glucose and should they pay for monitor and strips.

New DPP-4 and Glitazone Diabetes Drugs Will Account for 72% of the Diabetes Mark Posted: Thursday, October 05, 2006

According to a new report from Decision Resources, the New Novel Drug Classes Will Account for 76% of the Type 2 Diabetes Market by 2020, even though they are not even available in the US at this time.

EASD Recommends Earlier Insulin Therapy, Don’t Wait 4-6 years! Posted: Thursday, September 28, 2006

A Consensus Report launched at the annual meeting of the European Association for the Study of Diabetes, in Copenhagen, Denmark, is calling for urgent action to drastically improve the management of diabetes, particularly urging the increased acceptance of insulin. All patients with Type 2 diabetes, if they live long enough will require insulin.

Exubera Works Even with Cold or Flu-Study Posted: Thursday, September 21, 2006

A new form of insulin which is inhaled rather than injected works even if patients have a respiratory infections or are exposed to passive cigarette smoke.

MannKind Inhaled Insulin Matches Injections -Study Posted: Thursday, September 21, 2006

An inhaled insulin being developed by MannKind Corp produces comparable improvements in blood sugar control to rapid-acting insulin analog (RAA) given by injection, researchers said on Saturday.

Optimizing Control in Diabetes (OPTIMIZE) Survey Urges Action NOW! Posted: Thursday, September 21, 2006

Diabetes experts have warned that urgent action needs to be taken to drastically improve the management of diabetes to prevent a potentially devastating and costly global burden.

New Positive Data On Levemir, NovoRapid Posted: Thursday, September 21, 2006

Levemir improves glucose control without weight gain and hypoglycemia.

Inhaled Insulin Coming in September Posted: Thursday, August 31, 2006

It will be limited at first by the endo’s and then eventually by the family practitioner and internist. So how does it work?

New Wireless Device Aids in Diabetes Treatment Posted: Wednesday, August 23, 2006

Using the close-proximity wireless communications standard known as near-field communications (NFC) the device will link glucometers and insulin pumps.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.